Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response to Peg-interferon and Ribavirin for the Treatment of HCV Infection in HIV Co-infected Patients, Implemented in Public Hospitals in Thailand

NCT02247440 is registered in ClinicalTrials.gov with Institut de Recherche pour le Developpement as lead sponsor.

NCT NCT02247440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response to Peg-interferon and Ribavirin for the Treatment of HCV Infection in HIV Co-infected Patients, Implemented in Public Hospitals in Thailand
Lead sponsor
Institut de Recherche pour le Developpement
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
January 31, 2018
Enrollment
18 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c infection, hiv